Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sumatriptan 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.1 approved,investigational agonist
sumatriptan 5-hydroxytryptamine receptor 1b small molecule NA drugbank , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.82 approved,investigational agonist
sumatriptan 5-hydroxytryptamine receptor 1d small molecule NA drugbank , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.94 approved,investigational agonist
sumatriptan 5-ht 1d receptor NA Successful target TTD , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.94 approved unknown
sumatriptan 5-ht 1d receptor NA Successful target TTD , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.94 approved agonist
sumatriptan 5-hydroxytryptamine receptor 1f small molecule NA drugbank , DGIDB Cluster Headache[MeSHID:D003027]
Nose[MeSHID:D009666]
Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.34 approved,investigational agonist
click here to return to the previous page